<unk>  refers to a regimen consisting of etoposide, methylprednisolone (Solumedrol), high-dose cytarabine and cisplatin, used to treat relapsed and refractory Hodgkin's and Non-Hodgkin's lymphoma and rituximab added for the treatment of Diffuse large B-cell lymphoma.
ESHAP regimen
CT regimen
VAPEC-B regimen
CAPOX regimen
FLAG regimen
FLAMSA-BU regimen
FLAMSA regimen
IFL regimen